Access to anti-retroviral drugs, female (%) in Myanmar
Myanmar: Access to anti-retroviral drugs, female (%) was 78.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Myanmar, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Myanmar recorded 78.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 1.3% on the previous year and up 129.4% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Myanmar peaked at 78.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Myanmar 60th out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female (%) in Myanmar, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 1.0% | — |
| 2006 | 3.0% | +200.0% |
| 2007 | 5.0% | +66.7% |
| 2008 | 7.0% | +40.0% |
| 2009 | 9.0% | +28.6% |
| 2010 | 13.0% | +44.4% |
| 2011 | 16.0% | +23.1% |
| 2012 | 22.0% | +37.5% |
| 2013 | 28.0% | +27.3% |
| 2014 | 34.0% | +21.4% |
| 2015 | 42.0% | +23.5% |
| 2016 | 50.0% | +19.0% |
| 2017 | 56.0% | +12.0% |
| 2018 | 63.0% | +12.5% |
| 2019 | 68.0% | +7.9% |
| 2020 | 72.0% | +5.9% |
| 2021 | 76.0% | +5.6% |
| 2022 | 75.0% | -1.3% |
| 2023 | 77.0% | +2.7% |
| 2024 | 78.0% | +1.3% |
Myanmar compared with similar countries
- Myanmar's 78.0% is below the median for lower middle income countries, which is 80.0%, 98% of the median. (39 countries reporting)
- Myanmar's 78.0% is above the median for East Asia & Pacific, which is 71.0%, 1.1× the median. (15 countries reporting)
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, female (%) in Myanmar changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2006 | +200.0% | 1.0% | 3.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.5% | 0.0% | 9.0% | 10 |
| 2010s | 39.2% | 13.0% | 68.0% | 10 |
| 2020s | 75.6% | 72.0% | 78.0% | 5 |
Countries ranked near Myanmar
More gender data for Myanmar
- Child population (UN estimates and projections) 12,934 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.5781 % change on previous year (2030)
- Population 43,417 (2030)
- Working-age population (UN estimates and projections) 43,417 (2030)
- Population (UN estimates and projections), annual growth rate 0.7919 % change on previous year (2030)
- Age population, age 00, female, interpolated 421,278 (2025)
- Age population, age 00, male, interpolated 445,429 (2025)
- Age population, age 01, female, interpolated 422,232 (2025)
- Age population, age 01, male, interpolated 446,146 (2025)
- Age population, age 02, female, interpolated 423,553 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Myanmar?
- Access to anti-retroviral drugs, female in Myanmar was 78.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Myanmar?
- The highest recorded value was 78.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Myanmar?
- The lowest recorded value was 0.0% in 2000.
- How does Myanmar rank for access to anti-retroviral drugs, female?
- Myanmar ranks 60th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Myanmar?
- Over the last ten years it is up 129.4%. The long-run trend across the full record is volatile.
- Where does this Myanmar data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.